Saints Capital Leads $12 Mln Financing Round for AngioScore
AngioScore said Wednesday that it has received $12 million in PE financing led by Saints Capital. Existing institutional investors include Psilos Group Managers, Telegraph Hill Partners, QuestMark Partners, Pelion Venture Partners, California Technology Ventures and Innomed Ventures. Freemont, Calif.-based AngioScore is an endovascular company. Scott Halsted, a Saints Capital MD, was named to AngioScore's board.
20 April 2011•3 mins read
